Skip to main content

Table 2 Baseline characteristics of participants in a randomized controlled study

From: Scale development and an educational program to reduce the stigma of schizophrenia among community pharmacists: a randomized controlled trial

Characteristics

Educational lecture group

Contact-based intervention group

 

n = 56

n = 59

p

Gender, %female

41.1

42.4

0.89

Age, years: mean ± S.D.

36.8 ± 8.9

37.7 ± 10.0

0.82

Age group: %

 20–29

26.8

28.8

0.93

 30–39

37.5

32.2

 40–49

23.2

23.7

 50<

12.5

15.2

Pharmacist, years: mean ± S.D.

10.3 ± 6.9

11.9 ± 9.3

0.70

Psychiatric work experience, %positive

30.4

25.4

0.56

Experience of mental illness via a family member or close friend, %positive

32.1

32.2

0.99

Experience of schizophrenia via a family member or close friend, %positive

12.5

10.2

0.69

Frequency of medication counseling for schizophrenia patients, %positive

 Almost every day

0

1.7

0.37

 A few patients a week

12.5

11.9

 A few patients a month

42.9

39.0

 A few patients a year

21.4

32.2

 Nothing

23.2

15.3

SSCP, median (inter-quartile range)

74.0 (67.0–82.0)

71.0 (66.0–80.0)

0.276

Factor I, median (inter-quartile range)

32.0 (29.0–37.0)

31.0 (26.0–36.0)

0.242

Factor II, median (inter-quartile range)

20.0 (18.0–22.0)

20.0 (18.0–22.0)

0.840

Factor III, median (inter-quartile range)

12.0 (9.0–14.0)

11.0 (9.0–13.0)

0.336

Factor IV, median (inter-quartile range)

10.0 (9.0–11.8)

10.0 (8.0–12.0)

0.292

  1. Statistical analysis was performed using the chi-squared test or Mann-Whitney U test